The Fall of Tysabri ??????
Written: By Julie Stachowiak, Ph.D., Tysabri Discontinuation? Monday August 23, 2010 Looks like people at Biogen Idec and Elan Corp., makers…
Cladribine and Natalizumab can adversely interact
August 21, 2010 written by: Cherie C. Binns RN BS MSCN As I am researching interaction potential between Cladribine (may be…
Stuart Schlossman
Clinical Trial to Explore “Taking Breaks in Natalizumab (Tysabri®) Treatment”
This is a randomized, rater blinded trial in people who interrupt treatment with natalizumab with or without being treated with…
Stuart Schlossman
If caught early, Natalizumab-PML not fatal for multiple sclerosis patients
Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy (PML) and Immune Reconstitution Syndrome (IRIS) in a Patient With Multiple Sclerosis Alexandra Schröder, MD; De-Hyung Lee, MD;…
Stuart Schlossman
JCV Antibody Program: STRATIFY-2 for persons using Tysabri for Multiple Sclerosis
Information found below, was provided by Chris N, from Reno, NV. Subj: U.S. JCV Antibody Program: STRATIFY-2 All, I just…
Stuart Schlossman
Recommendation for treatment of progressive multifocal leukoencephalopathy (PML) with Natalizumab #ENS2010
Information provided by Penny in South Florida June 21, 2010 In the name of the Medical Advisory Board of the…
Stuart Schlossman
PML Cases rise by (3)
Reported by Karen M. Biogen: Total PML Cases At 49, Deaths At 11 As Of May 6 By Thomas Gryta,…
Stuart Schlossman
A Patient writes about Tysabri: Is the Benefit Worth the Risk?
Kim writes from her MS Blog: My Sun Still Rises This Friday, I will receive my 24th infusion of what…
Stuart Schlossman
Signs of PML
Borrowed from Kim’s “My sun still rises” MS Blog Signs of PML: Typical symptoms associated with PML progress quickly over…
Stuart Schlossman
Mouse DNA Stops Progression Of Multiple Sclerosis
By Dayle Cedars, 7NEWS Reporter Patients Get Infusion Of Tysabri Every Four Weeks AURORA, Colo. — A tiny creature could…
Stuart Schlossman
